These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1728188)
1. Clozapine-induced weight gain: prevalence and clinical relevance. Leadbetter R; Shutty M; Pavalonis D; Vieweg V; Higgins P; Downs M Am J Psychiatry; 1992 Jan; 149(1):68-72. PubMed ID: 1728188 [TBL] [Abstract][Full Text] [Related]
2. Weight gain among schizophrenic patients treated with clozapine. Lamberti JS; Bellnier T; Schwarzkopf SB Am J Psychiatry; 1992 May; 149(5):689-90. PubMed ID: 1349460 [TBL] [Abstract][Full Text] [Related]
3. Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Kluge M; Schuld A; Schacht A; Himmerich H; Dalal MA; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T Psychoneuroendocrinology; 2009 Jan; 34(1):118-28. PubMed ID: 18835660 [TBL] [Abstract][Full Text] [Related]
4. Clozapine and weight gain. Umbricht DS; Pollack S; Kane JM J Clin Psychiatry; 1994 Sep; 55 Suppl B():157-60. PubMed ID: 7961563 [TBL] [Abstract][Full Text] [Related]
11. Weight gain associated with clozapine. Cohen S; Chiles J; MacNaughton A Am J Psychiatry; 1990 Apr; 147(4):503-4. PubMed ID: 2316740 [TBL] [Abstract][Full Text] [Related]
12. [Weight gain in patients with schizophrenia and schizoaffective disorder induced by the long-term treatment with atypical antipsychotics]. Gorobets LN Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(9):52-6. PubMed ID: 18833173 [TBL] [Abstract][Full Text] [Related]
13. Clozapine, negative symptoms, and extrapyramidal side effects. Kane JM; Safferman AZ; Pollack S; Johns C; Szymanski S; Kronig M; Lieberman JA J Clin Psychiatry; 1994 Sep; 55 Suppl B():74-7. PubMed ID: 7961579 [TBL] [Abstract][Full Text] [Related]
14. Clozapine treatment in polydipsia and intermittent hyponatremia. Spears NM; Leadbetter RA; Shutty MS J Clin Psychiatry; 1996 Mar; 57(3):123-8. PubMed ID: 8617697 [TBL] [Abstract][Full Text] [Related]
15. Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. Daniel DG; Goldberg TE; Weinberger DR; Kleinman JE; Pickar D; Lubick LJ; Williams TS Am J Psychiatry; 1996 Mar; 153(3):417-9. PubMed ID: 8610833 [TBL] [Abstract][Full Text] [Related]
16. Clinical effects of a randomized switch of patients from clozaril to generic clozapine. Kluznik JC; Walbek NH; Farnsworth MG; Melstrom K J Clin Psychiatry; 2001; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843 [TBL] [Abstract][Full Text] [Related]
17. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479 [TBL] [Abstract][Full Text] [Related]
18. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea. Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Suppes T; Webb A; Paul B; Carmody T; Kraemer H; Rush AJ Am J Psychiatry; 1999 Aug; 156(8):1164-9. PubMed ID: 10450255 [TBL] [Abstract][Full Text] [Related]
20. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses. Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]